Anlon Healthcare Delivers Over 102% Profit Growth in H1 FY26 & 259% in Q2FY26 Driven by Robust R&D and Expanding API Portfolio
Nov 13, 2025
Rajkot (Gujarat) [India], November 13: Anlon Healthcare Limited, one of India's leading manufacturers of high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs), announced its unaudited financial results for the second Q2 and H1 FY26.
Read More...